Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemotherapy followed by surgery for locally advanced cervical cancer
IRCT2017090236033N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and paclitaxel in Cervical Cancer (CC), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Pathologic response, Side effects and 1 more. Started Dec 2016; status: completed.
02
Drugs
cisplatinpaclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on IRCT2017090236033N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017090236033N1.